Laser Efficiency on Metabolic Parameters

Completed

• Conditions: Metabolic Syndrome
• Interventions: Device: non-invasive laser therapy

• Registration Number: NCT06193746
• Lead Sponsor: Cairo University

Brief Summary

Non-invasive laser therapy is laser blood irradiation improves many metabolic parameters. So, this study aims to assess the impact of Non-invasive laser therapy on lipid metabolism and renal out comes

Detailed Description

The metabolic syndrome is a constellation of interrelated metabolic risk factors especially central obesity, dyslipidemia, hyperglycemia, which all affect worse their kidney function, and all of this causing mortality. This time line requires a quick procedure that will enable us to implement safe and non-invasive therapeutic instruments adjacent therapy for metabolic syndrome cases.

Study Timeline

• Study Start: 2023-04-10
• Primary Completion: 2023-06-30
• Study Completion: 2023-10-10
• Status Verified: 2023-12
• Study First Submitted: 2023-12-11
• Study First Submitted QC: 2023-12-21
• Last Update Submitted: 2023-12-21
• Study First Posted: 2024-01-05
• Last Update Posted: 2024-01-05

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

• The patients have Metabolic syndrome, started more than one year ago.
• BMI ranged 30- 35Kg/m2.
• They are on medical therapy for more than one year.
• Clinically stable.

Exclusion Criteria

• taking specific drugs uncontrolled diseases
• cardiovascular instability
• sever e autonomic neuropathy
• infection wound,
• burn, allergy or another external injury
• hypothyroidism
• hemorrhagic disorders
• history of cancer
• pregnant women,
• mental illness as schizophrenia or dementia.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
study group	non-invasive laser therapy	wear the laser watch on wrist 3times/weak up to 30 minute for 12 weeks ,

Primary Outcome Measures

Name	Time	Method
lipid profile change	12 weeks following end of treatment	laboratorial measurement of lipid in one mg/dl of blood
glomerular function range change	12 weeks following end of treatment	laboratorial measurement of glomerular function range in one ml of blood/1minute/1.73m2
creatinine change	12 weeks following end of treatment	laboratorial measurement of creatinine one mg/DL of blood

Trial Locations

Locations (1)

Toka; 🇪🇬 Cairo, Egypt